Other T-cell surface antigens

The term "Other T-cell surface antigens" refers to a broad and heterogeneous category of proteins expressed on the plasma membrane of T-lymphocytes that are not classified under primary headings such as the T-cell receptor (TCR) complex, CD4, CD8, or major immune checkpoints like PD-1 and CTLA-4. This group typically includes various Cluster of Differentiation (CD) markers—such as CD2, CD7, CD25, and CD30—as well as co-stimulatory molecules and adhesion receptors that facilitate T-cell activation, signaling, and trafficking (Janeway et al., Immunobiology, 2001; Abbas et al., Cellular and Molecular Immunology, 2017). Because this is a collective designation rather than a single receptor or enzyme, it does not possess a uniform biological function or a specific pharmacological profile. In drug development and clinical trial registries, this label is frequently used as a placeholder for diverse immunotherapy targets or for antigens whose specific roles are still being characterized in the context of hematologic malignancies and autoimmune diseases (NCI Thesaurus). Consequently, the therapeutic utility and safety considerations associated with this classification are entirely dependent on the specific molecular antigen being addressed in a given clinical or research context (Zola et al., Pathology, 2007).

Other names

T-cell surface markersMiscellaneous T-lymphocyte antigensT-cell differentiation antigens

The mechanism of action varies significantly depending on the specific antigen targeted within this category; common mechanisms include antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and the delivery of cytotoxic conjugates to T-cells (e.g., via CD30 or CD25).